Development of a STAT5 Phosphorylation Assay as a Rapid Bioassay to Assess Interleukin-7 Potency

被引:1
|
作者
Zumpe, C. [1 ,2 ]
Engel, K. [1 ]
Wiedemann, N. [1 ]
Metzger, A. U. [1 ]
Pischetsrieder, M. [2 ]
Bachmann, C. L. [1 ]
机构
[1] Merck KGaA, Analyt Dev Biotech Prod, Darmstadt, Germany
[2] Univ Erlangen Nurnberg, Inst Pharm & Food Chem, D-91054 Erlangen, Germany
关键词
Bioassay; interleukin-7; kit; 225; cells; phosphorylation assay; proliferation assay; quality control; STAT5; PRIMARY HUMAN T; PHOSPHATIDYLINOSITOL; 3-KINASE; ACTIVATION; RECEPTOR; KINASES; IL-7; ASSOCIATION; PROTEINS; INDUCE; ROLES;
D O I
10.2174/138920111798357294
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin (IL)-7 is a cytokine inducing the Janus Kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) pathway. As a consequence of IL-7 activating this pathway, STAT5 is phosphorylated. In pharmaceutical quality control, the potency of biopharmaceuticals is commonly assessed by proliferation assays. This is also possible for IL-7 conjugates. However, the disadvantage of these classical "endpoint-assays" is that they require very long incubation times, up to several days, since they measure the downstream events of a cellular response. As an alternative to this, we developed a rapid intracellular phosphorylation assay, measuring IL-7 induced STAT5 phosphorylation in Kit 225 cells. The Kit 225 human T cell line expresses the IL-7 receptor and is responsive to IL-7, therefore making it a good candidate cell line for assay development. Like the Kinase receptor activation (KIRA) assay, developed by Sadick et al. [1], the STAT5 phosphorylation assay was performed using two separate microtiter plates: the first one for cell stimulation and lysis, the second one for enzyme-linked immuno sorbent assay (ELISA). The assay showed a high accuracy and precision with a mean recovery of 102% and a mean coefficient of variation of 9%. In comparison to the classical proliferation assay, the phosphorylation assay is much faster. Thus, the assay procedure time can at least be reduced from six to three days by using STAT5 phosphorylation instead of proliferation as an endpoint due to the shorter incubation time with IL-7. Moreover, the phosphorylation assay shows a wider dynamic range and higher signal to noise ratios and is thus more robust than the proliferation assay. mAs a consequence, this assay could serve as reliable, accurate, precise and fast alternative to the classical proliferation assay for IL-7. This study also serves as an example for the typical steps during development and qualification/validation of a potency assay for quality control testing.
引用
收藏
页码:1580 / 1588
页数:9
相关论文
共 42 条
  • [21] STAT5 Phosphorylation Status by Flow Cytometry Is a Rapid and Reliable Tool for Diagnosis and Follow-up of Juvenile Myelomonocytic Leukemia
    Gaipa, Giuseppe
    Bugarin, Cristina
    Giordan, Marco
    Bresolin, Silvia
    Hasegawa, Daisuke
    Zecca, Marco
    Longoni, Daniela
    Menna, Simone
    Basso, Giuseppe
    Kronnie, Geertruy Te
    Biondi, Andrea
    BLOOD, 2010, 116 (21) : 1134 - 1135
  • [22] STAT5 activation underlies IL7 receptor-dependent B cell development
    Goetz, CA
    Harmon, IR
    O'Neil, JJ
    Burchill, MA
    Farrar, MA
    JOURNAL OF IMMUNOLOGY, 2004, 172 (08): : 4770 - 4778
  • [23] IL-7 response defined by STAT5 phosphorylation in the reconstituting CMV-specific immune system after HSCT
    Perez-Bercoff, L.
    Kumar-Vudattu, N.
    Byrareddy, S.
    Maeurer, M.
    Ljungman, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S135 - S136
  • [24] Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5
    Bertolino, E
    Reddy, K
    Medina, KL
    Parganas, E
    Ihle, J
    Singh, H
    NATURE IMMUNOLOGY, 2005, 6 (08) : 836 - 843
  • [25] A novel flow cytometric assay for measurement of phosphorylated STAT5 in peripheral blood mommuclear cells of melanoma patients receiving interleukin-2
    Varker, KA
    Go, MR
    Lesinski, GB
    Kondadasula, SV
    Monk, JP
    Carson, WE
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S42 - S42
  • [26] Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of Stat5
    Sexl, V
    Piekorz, R
    Moriggl, R
    Rohrer, J
    Brown, MP
    Bunting, KD
    Rothammer, K
    Roussel, MF
    Ihle, JN
    BLOOD, 2000, 96 (06) : 2277 - 2283
  • [27] Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients
    Thiant, S.
    Moutuou, M. M.
    Laflamme, P.
    Boumedine, R. Sidi
    Leboeuf, D. M.
    Busque, L.
    Roy, J.
    Guimond, M.
    BLOOD CANCER JOURNAL, 2017, 7 : e551 - e551
  • [28] Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients
    S Thiant
    M M Moutuou
    P Laflamme
    R Sidi Boumedine
    D M Leboeuf
    L Busque
    J Roy
    M Guimond
    Blood Cancer Journal, 2017, 7 : e551 - e551
  • [29] Constitutive association of JAK1 and STAT5 in pro-B cells is dissolved by interleukin-4-induced tyrosine phosphorylation of both proteins
    Erhardt, I
    Lischke, A
    Sebald, W
    Friedrich, K
    FEBS LETTERS, 1998, 439 (1-2) : 71 - 74
  • [30] Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (beta(IL3)) and recruitment of Stat5 to possible Stat5-docking sites in beta(IL3)
    Chin, H
    Wakao, H
    Miyajima, A
    Kamiyama, R
    Miyasaka, N
    Miura, O
    BLOOD, 1997, 89 (12) : 4327 - 4336